Schonfeld Strategic Advisors LLC Ardelyx, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 250,067 shares of ARDX stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,067
Previous 764,024
67.27%
Holding current value
$1.45 Million
Previous $5.58 Million
66.79%
% of portfolio
0.01%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding ARDX
# of Institutions
208Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$150 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$78.9 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$69.2 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$39.9 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $894M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...